Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Novo nordisk a/s has detected that the insulin cartridge holder used in a select number of novopen echo and novopen 5 lots may crack or break if exposed to certain chemicals for example certain cleaning agents. novopen echo and novopen 5 are used for insulin treatment by people living with diabetes. novopen 4 and flextouch are not impacted.